- With the goal of doubling these savings by 2025, the new offerings will help drive clinical efficiency, enhance patient comfort and improve workflow
Dubai, UAE: At Arab Health 2020, GE Healthcare today launched more than 30 new imaging intelligent applications and smart devices designed to drive efficiency in clinics and hospitals, aiming to double productivity and cost savings for systems by 2025.
For healthcare executives, the new offerings help save costs, improve technology utilization, and increase patient volumes. Clinicians also will benefit from intuitive workflows, improved diagnostic confidence and less rework, allowing them to devote more time for patients.
“Now, more than ever, clinicians face tremendous pressure to deliver optimal patient care and clinical outcomes with fewer resources,” said Kieran Murphy, President and CEO of GE Healthcare. “By integrating data, intelligent software applications, and smart devices, we’re enabling clinicians to make faster, more informed decisions to give them time with what matters most: their patients.”
Healthcare inefficiencies lead to nearly $1 trillion of annual financial waste in the United States alone.1 Healthcare executives report costs and transparency as their number one concern and need new solutions to help solve these challenges.2 Recognizing the opportunity to reduce waste and increase efficiency across the healthcare industry, GE Healthcare is presenting new intelligent applications and smart devices at Arab Health 2020 being held until January 30 at Dubai World Trade Center.
Several of these new smart devices and intelligent applications were developed using Edison, GE Healthcare’s secure intelligence platform that helps both GE Healthcare developers and select strategic partners to design, develop, manage, secure and distribute advanced applications, services and artificial intelligence (AI) algorithms quickly. The innovative solutions include:
AIR™ Recon DL3, an Edison application providing True Fidelity images, is a GE-first, deep- learning MRI reconstruction technology application designed to improve signal-to-noise and image sharpness and enable shorter scan times. This application was developed using a neural network trained on tens of thousands of images using GE’s Edison AI Platform.
Critical Care Suite is an industry-first, FDA cleared collection of AI algorithms embedded on a mobile X-ray device for triage. Built in collaboration with clinical partners, using GE Healthcare’s Edison platform, the AI algorithms help reduce the turn-around time for radiologists to review a suspected pneumothorax, a type of collapsed lung. Additionally, Critical Care Suite’s quality AI algorithms help technologists reduce image quality errors and improve efficiency by simultaneously auto rotating images as well as analyzing and flagging protocol and field of view errors on-device. The Intelligent Auto Rotate AI alone can save highly-trained technologists at a medium to large size hospital more than 70,000 manual clicks4 – that amounts to nearly 20 hours, or three working days a year spent rotating chest images on portable X-ray machines.
Edison™ Open AI Orchestrator is designed to orchestrate AI at scale for imaging workflows. The new Edison Open AI Orchestrator simplifies the implementation, deployment, support and scaling of multiple AI applications including from partners iCAD and MaxQ. Designed to seamlessly integrate clinical applications into the radiology PACS eading workflow, this offering reduces the complexity of multiple systems and algorithms working together that could lead to error and risk if implemented incorrectly.
Revolution™ Maxima with AI-Based Auto Positioning5 is a powerful, high performing and reliable CT that maximizes every step of the CT workflow, from referral to report. Enabled with AI-based Auto Positioning technology, Revolution Maxima uses real-time depth sensing technology to generate a 3D model of a patient’s body to pinpoint the center of the scan range and automatically align it to the isocenter of the bore. Altogether, it is designed to simplify, streamline and automate the entire CT experience for one click, hands-free patient positioning.
OEC Touch for OEC Elite CFD features a new control panel located right on the C-arm. During a variety of clinical procedures, C-arm technicians often move back-and-forth between the C-arm. While these movements are necessary, they can disrupt surgical flow and cause inefficiencies and block the surgeon’s view of the images during procedures. The new control panel, OEC Touch, is designed to eliminate the need to move to a separate workstation and reduce disruption during surgery.
Embo ASSIST6 with Virtual Injection is an Edison application designed to help clinicians perform complex embolization procedures. It helps analyze the vasculature and simulate injections dynamically to help determine the embolization strategy to avoid embolizing healthy tissues in the brain or prostate with just one click. It is designed to provide clinicians with an intuitive solution to support clinical decision-making and drive efficiency in the interventional suite.
Clinical Command Centers are designed to improve outcomes and efficiency with new real-time decision support tools along with process improvement targeted using digital twins of patient flow. Each Clinical Command Center features 5–20 decision support apps or “Tiles” which are used systemwide as well as in the command center to pinpoint opportunities to reduce length of stay, increase imaging utilization, get ahead of patient bottlenecks or issues and much more.
Updates to GE Healthcare’s portfolio follow the launch of the Edison Developer Program which expands the Edison ecosystem to accelerate the adoption and impact of advanced applications and developer services across health systems. The Edison Developer Program helps healthcare providers gain easier access to market-ready algorithms and applications by directly integrating these technologies into existing workflows.
GE Healthcare is showcasing its efficiency-focused applications and devices at Arab Health at Dubai World Trade Center, Sheikh Saeed Hall, Booth SB310.
3 510(k) pending at FDA. Not available for sale in the United States.
4 GE Healthcare Data on File.
5 510(k) pending at FDA. Not available for sale in the United States.
6 Embo ASSIST solution includes FlightPlan For Embolization, Vision 2, VesselIQ Xpress, Autobone Xpress and requires AW workstation with Volume Viewer, Volume Viewer Innova. These applications are sold separately. FlightPlan for Embolization is 510(k) pending at FDA. Not available for sale in the United States.
About GE Healthcare:
GE Healthcare is the $19.8 billion healthcare business of GE (NYSE: GE). As a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, the company helps improve outcomes more efficiently for patients, healthcare providers, researchers and life sciences companies around the world. Follow us on Facebook, LinkedIn, Twitter and Insights for latest news, or visit our website https://corporate.gehealthcare.com/ for more information.
Certain statements in this press release are forward-looking. Any descriptions of future functionality reflect current product direction, are for informational purposes only, and do not constitute a commitment to provide specific functionality. Timing and availability are subject to change and applicable regulatory approvals.
For more information:
Nader Abou-Guendia Kelly Home | Nivine William
GE Healthcare – Eastern Growth Markets ASDA’A BCW
+9714 4296588 +9714 4507600
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.